Post COVID-19 Retinal Evaluation Using Optical Coherence Tomography Angiography: A Case Control Study

References

• Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-9.
   PubMed Web of Science ®Google Scholar
• Coronavirus Outbreak. https://www.worldometers.info/coronavirus/. Accessed May 3rd, 2022.
   Google Scholar
• Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. John Wiley & Sons Hoboken, New Jeresy, U.S. ; 2020.
   Google Scholar
• Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7.
   PubMed Web of Science ®Google Scholar
• Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56(2):106024. doi:10.1016/j.ijantimicag.2020.106024.
   PubMed Web of Science ®Google Scholar
• Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003–1008. doi:10.1111/jce.14479.
   PubMed Web of Science ®Google Scholar
• Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(3):247–250.doi:10.1016/j.dsx.2020.03.013.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published correction appears in Lancet Respir Med. 2020; 8(4):e26]. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032.
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127.
   PubMed Web of Science ®Google Scholar
• Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576. doi:10.1056/NEJMc2009191.
   PubMed Web of Science ®Google Scholar
• Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261. doi:10.1007/s00405-020-05965-1.
   PubMed Web of Science ®Google Scholar
• Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212–e213. doi:10.1111/jdv.16387.
   PubMed Web of Science ®Google Scholar
• Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028. doi:10.1515/cclm-2020-0369.
   PubMed Web of Science ®Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:10.1080/09273948.2020.1738501.
   PubMed Web of Science ®Google Scholar
• Dockery DM, Rowe SG, Murphy MA, Krzystolik MG. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J Emerg Med. 2020;59(1):137–140. doi:10.1016/j.jemermed.2020.04.060.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-Up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–2973. doi:10.1016/j.jacc.2020.04.031.
   PubMed Web of Science ®Google Scholar
• Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:10.1016/S0140-6736(20)31014-X.
   PubMed Web of Science ®Google Scholar
• Criteria to release COVID-19 patients from isolation: scientific brief. https://www.who.int/news-room/commentaries/detail/criteria-for-releasing-covid-19-patients-from-isolation. Published Jun 2021. Accessed Nov 2021.
   Google Scholar
• Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J Clin Med. 2020; 9(6): 1753.Published 2020 Jun 5. doi:10.3390/jcm9061753.
   PubMed Web of Science ®Google Scholar
• Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1–55. doi:10.1016/j.preteyeres.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–918. doi:10.1016/j.jamda.2020.05.045.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Ali A, Hasan S. Comparison of epidemiological variations in COVID-19 patients inside and outside of China-A meta-analysis. Front Public Health. 2020;8:193. Published 2020 May 8. doi:10.3389/fpubh.2020.00193.
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017.
   PubMed Web of Science ®Google Scholar
• González-Zamora J, Bilbao-Malavé V, Gándara E, et al. Retinal microvascular impairment in COVID-19 bilateral pneumonia assessed by optical coherence tomography angiography. Biomedicines. 2021; 9(3): 247.Published 2021 Mar 2. doi:10.3390/biomedicines9030247.
   PubMed Web of Science ®Google Scholar
• Abrishami M, Emamverdian Z, Shoeibi N, et al. Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study. Can J Ophthalmol. 2021;56(1):24–30. doi:10.1016/j.jcjo.2020.11.006.
   PubMed Web of Science ®Google Scholar
• Murakami T, Tsujikawa A, Miyamoto K, et al. Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusion. Eye (Lond). 2012;26(6):771–780. doi:10.1038/eye.2012.85.
   PubMed Web of Science ®Google Scholar
• Soares M, Neves C, Marques IP, et al. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. 2017;101(1):62–68. doi:10.1136/bjophthalmol-2016-309424.
   PubMed Web of Science ®Google Scholar
• Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005;206(4):319–348. doi:10.1111/j.1469-7580.2005.00395.x.
   PubMed Web of Science ®Google Scholar
• Eldaly Z, Soliman W, Sharaf M, Reyad AN. Morphological characteristics of normal foveal avascular zone by optical coherence tomography angiography. J Ophthalmol. 2020;2020:8281459. Published 2020 Aug 19. doi:10.1155/2020/8281459.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5.
   PubMed Web of Science ®Google Scholar
• Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128(8):1214–1236. doi:10.1161/CIRCRESAHA.121.317997.
   PubMed Web of Science ®Google Scholar
• Savastano MC, Gambini G, Cozzupoli GM, et al. Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study. Graefes Arch Clin Exp Ophthalmol. 2021;259(8):2157–2165. doi:10.1007/s00417-020-05070-3.
   PubMed Web of Science ®Google Scholar
• Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. E Clin Med. 2020;27:100550.
   Google Scholar
• Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2020;34(12):2352–2353. doi:10.1038/s41433-020-1069-8.
   PubMed Web of Science ®Google Scholar
• Tjendra Y, Al Mana AF, Espejo AP, et al. Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med. 2020;144(12):1465–1474. doi:10.5858/arpa.2020-0471-SA.
   PubMed Web of Science ®Google Scholar
• Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res. 2004;30(3):261–277. doi:10.1385/IR:30:3:261.
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. Published 2018 Apr 13. doi:10.3389/fimmu.2018.00754.
   PubMed Web of Science ®Google Scholar
• Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B, et al. Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection. Med Clin (Barc). 2021;156(11):541–546. doi:10.1016/j.medcli.2020.12.006.
   PubMed Web of Science ®Google Scholar
• Cennamo G, Reibaldi M, Montorio D, D’Andrea L, Fallico M, Triassi M. Optical coherence tomography angiography features in post-COVID-19 pneumonia patients: a pilot study. Am J Ophthalmol. 2021;227:182–190. doi:10.1016/j.ajo.2021.03.015.
   PubMed Web of Science ®Google Scholar
• Che Mohd Nassir CMN, Hashim S, Wong KK, et al. COVID-19 infection and circulating microparticles-reviewing evidence as microthrombogenic risk factor for cerebral small vessel disease. Mol Neurobiol. 2021;58(8):4188–4215. doi:10.1007/s12035-021-02457-z.
   PubMed Web of Science ®Google Scholar
• Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173(4):268–277. doi:10.7326/M20-2003.
   PubMed Web of Science ®Google Scholar
• Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725. doi:10.1080/09273948.2020.1770301.
   PubMed Web of Science ®Google Scholar
• Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th Anniversary of the discovery of ACE2. Circ Res. 2020;126(10):1456–1474. doi:10.1161/CIRCRESAHA.120.317015.
   PubMed Web of Science ®Google Scholar
• Huertas A, Montani D, Savale L, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020; 56(1): 2001634.Published 2020 Jul 30. doi:10.1183/13993003.01634-2020.
   PubMed Web of Science ®Google Scholar